A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1

Artigo Acesso aberto Revisado por pares

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1

2013; BMJ; Volume: 68; Issue: 11 Linguagem: Inglês

10.1136/thoraxjnl-2013-203309

ISSN

1468-3296

Autores

Eric W.F.W. Alton, A. Christopher Boyd, Seng H. Cheng, Steve Cunningham, Jane C. Davies, Deborah R. Gill, Uta Griesenbach, Tracy Higgins, Stephen C. Hyde, J. Alastair Innes, Gordon Murray, David J. Porteous,

Tópico(s)

Energy Harvesting in Wireless Networks

Resumo

The UK Cystic Fibrosis Gene Therapy Consortium has been working towards clinical gene therapy for patients with cystic fibrosis for several years. We have recently embarked on a large, multi-dose clinical trial of a non-viral, liposome-based formulation powered for the first time to detect clinical benefit. The article describes the details of the protocol.

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1